High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania

Clinical Infectious Diseases

Volumn 40, Issue 10, 2005, Pages 1500-1507

  Mtei, Lillian ^a   Matee, Mecky ^a   Herfort, Oliver ^b   Bakari, Muhammad ^a   Horsburgh, C Robert ^c   Waddell, Richard ^b   Cole, Bernard F ^b   Vuola, Jenni M ^e,f   Tvaroha, Susan ^b   Kreiswirth, Barry ^d   Pallangyo, Kisali ^a   Fordham Von Reyn, C ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f GLAXOSMITHKLINE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM ANTIGEN;

ACID FAST BACTERIUM; ADULT; AMBULATORY MONITORING; ARTICLE; BCG VACCINATION; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MYCOBACTERIUM; PRIORITY JOURNAL; SPUTUM CULTURE; TANZANIA; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; TANZANIA; TUBERCULOSIS;

EID: 20944449545     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429825     Document Type: Article

References (28)

1. Whalen CC, Nsubuga P, Okwera A, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000; 14:1219-28.
2. Godfrey-Faussett P, Maher D, Mukadi YD, Nunn P, Perriens J, Raviglione M. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ 2002; 80:939-45.
3. Frieden T, Sterling TR, Munsliff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362:887-99.
4. Nunn PP, Elliott AM, McAdam KP. Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax 1994; 49:511-8.
5. Johnson JL, Okwera A, Hom DL, et al. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS 2001; 15:2137-47.
6. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357:1519-23.
7. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337:801-8.
8. Quigley MA, Mwinga A, Hosp M, et al. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS 2001; 15:215-22.
9. Mwinga A, Hosp M, Godfrey-Fausset P, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12:2447-57.
10. World Health Organization. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999; 74:385-400.
11. Archibald LK, den Dulk MO, Pallangyo KJ, Reller LB. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis 1998; 26:290-6.
12. von Reyn CF. The significance of bacteremic tuberculosis among persons with HIV infection in developing countries. AIDS 1999; 13:2193-5.
13. Vuola J, Ristola M, Cole B, et al. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. AIDS 2003; 17:2351-5.
14. Crump JA, Tanner DC, Mirrett S, McKnight CM, Reller LB. Controlled comparison of BACTEC 13 A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J Clin Microbiol 2003; 41:1987-90.
15. Bifani PJ, Mathema B, Liu Z, et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999; 24:2321-7.
16. Desormeaux J, Johnson MP, Coberly JS, et al. Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Bull Pan Am Health Organ 1996; 30:1-8.
17. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active casefinding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 2003; 17:1398-400.
18. Kimerling ME, Schucter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002; 6:988-94.
19. Harries AD. Tuberculosis in HIV-infected persons with special emphasis on sub-Saharan Africa. J Infect 1998; 37:205-9.
20. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292-7.
21. Perlman DC, El-Sadr WM, Nelson ET, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis 1997; 25:242-6.
22. Kent DC, Reid D, Sokolowski JW, Houk VN. Tuberculin conversion: the iceberg of tuberculous pathogenesis. Arch Environ Health 1967; 14:580-4.
23. Carter EJ, Mates S. Tuberculosis during pregnancy: the Rhode Island experience, 1997 to 1991. Chest 1994; 106:1466-70.
24. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex-vivo analysis of antigen specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167:5217-25.
25. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40:704-6.
26. Mosimaneotsile B, Talbot EA, Moeti TL, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003; 362:1551-2.
27. Council MR. The treatment of pulmonary tuberculosis with isoniazid. Brit Med J 1952; 2:735-46.
28. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151:129-35.